Serge Goblet: The Visionary Empire of 159 Million Euros, from Commerce to Revolutionary Biotechnology
Serge Goblet, a Belgian investor with an estimated fortune of 159 million euros, has built a diversified empire combining commerce, real estate and biotechnology. His flagship investment, Celyad Oncology SA, develops innovative CAR-T cancer therapies. Goblet illustrates the successful alliance between entrepreneurial spirit and medical innovation, contributing to therapeutic advances while consolidating a portfolio of international assets in various sectors.